» Articles » PMID: 32566457

The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour

Overview
Date 2020 Jun 23
PMID 32566457
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of TFE3 (transcription factor E3) in solitary fibrous tumours (SFTs) and their histologic mimickers was investigated, and the diagnostic value and clinical significance of TFE3 nuclear expression in SFTs were explored. Immunohistochemical analysis for TFE3 was performed on 50 cases of SFTs that were surgically resected. The controls were sample tissues from malignant peripheral nerve sheath tumour, synovial sarcoma, dedifferentiated liposarcoma, spindle cell lipoma, and dermatofibrosarcoma protuberans. The survival of patients with TFE3-positive and TFE3-negative expressions was assessed through the Kaplan-Meier analysis. In 44 of 50 (88%) SFTs, nuclear immunoreactivity for TFE3 was detected. The TFE3 expression was negative in all samples of synovial sarcoma, malignant peripheral nerve sheath tumour, dermatofibrosarcoma protuberans, and spindle cell lipoma and weakly positive in 2 of 10 cases of dedifferentiated liposarcoma. Fluorescence in situ hybridization (FISH) confirmed that the expression of the TFE3 protein is not caused by gene translocation. There was no statistical significance between the association of the TFE3 expression and SFT patient prognosis. Therefore, TFE3 is capable of enhancing the differential diagnosis of SFTs and their histologic mimickers and can be potentially used as a diagnostic marker. The findings also offer valuable insights into SFT diagnosis, aetiology, and associated molecular mechanisms.

Citing Articles

Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile.

Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M Cureus. 2024; 16(3):e56899.

PMID: 38659562 PMC: 11042756. DOI: 10.7759/cureus.56899.


Metastatic Epithelioid Pleomorphic Liposarcoma in the Brain: A Case Report.

Wang T, Waworuntu K, Shan F Cureus. 2024; 15(12):e50066.

PMID: 38186523 PMC: 10769534. DOI: 10.7759/cureus.50066.


A review of neoplasms with MITF/MiT family translocations.

Wei S, Testa J, Argani P Histol Histopathol. 2022; 37(4):311-321.

PMID: 35107169 DOI: 10.14670/HH-18-426.

References
1.
Brady O, Jeong E, Martina J, Pirooznia M, Tunc I, Puertollano R . The transcription factors TFE3 and TFEB amplify p53 dependent transcriptional programs in response to DNA damage. Elife. 2018; 7. PMC: 6292694. DOI: 10.7554/eLife.40856. View

2.
Haq R, Fisher D . Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. J Clin Oncol. 2011; 29(25):3474-82. DOI: 10.1200/JCO.2010.32.6223. View

3.
Schoolmeester J, Lastra R . Granular cell tumors overexpress TFE3 without corollary gene rearrangement. Hum Pathol. 2015; 46(8):1242-3. DOI: 10.1016/j.humpath.2015.04.004. View

4.
Robinson D, Wu Y, Kalyana-Sundaram S, Cao X, Lonigro R, Sung Y . Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013; 45(2):180-5. PMC: 3654808. DOI: 10.1038/ng.2509. View

5.
Vivero M, Doyle L, Fletcher C, Mertens F, Hornick J . GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling. Histopathology. 2014; 65(1):71-80. DOI: 10.1111/his.12377. View